A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?

Overview of attention for article published in Frontiers in endocrinology, March 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 43 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,919 followers.

New article: A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome? https://t.co/IFvBmViAQJ #lungcancer #oncology https://t.co/dAikZFtl

18 Mar 2022

Reply Repost Favourite

Our recent study showed that the inactivated #SARSCoV2 #vaccine (BBIBP-CorV) is a tolerable and effective method to prevent #COVID19 in patients #breast #cancer https://t.co/oBUtIvWtbw

04 Mar 2022

Reply Repost Favourite

New Research: A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?: Aim To determine the efficacy and safety… https://t.co/hFX4Vg99S

01 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.